Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis

Vet Res Commun. 2008 Sep:32 Suppl 1:S303-5. doi: 10.1007/s11259-008-9134-y.
No abstract available

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Animals
  • Antibodies, Protozoan / blood
  • Antiprotozoal Agents / therapeutic use*
  • Dog Diseases / drug therapy*
  • Dog Diseases / parasitology*
  • Dogs
  • Drug Therapy, Combination
  • Leishmaniasis / drug therapy
  • Leishmaniasis / veterinary*
  • Meglumine / therapeutic use*
  • Meglumine Antimoniate
  • Metronidazole / therapeutic use*
  • Organometallic Compounds / therapeutic use*
  • Spiramycin / therapeutic use*
  • Treatment Outcome

Substances

  • Antibodies, Protozoan
  • Antiprotozoal Agents
  • Organometallic Compounds
  • Metronidazole
  • Meglumine
  • Meglumine Antimoniate
  • Spiramycin